Ranibizumab 0.5mg and 2.0mg to Treat Diabetic Macular Edema in Patients With Poor Response to Bevacizumab (REEF)
This study is ongoing, but not recruiting participants.
Sponsor:
California Retina Consultants
Collaborator:
Genentech
Information provided by (Responsible Party):
California Retina Consultants
ClinicalTrials.gov Identifier:
NCT01292798
First received: February 7, 2011
Last updated: December 6, 2012
Last verified: December 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | March 2013 |
| Estimated Primary Completion Date: | December 2012 (Final data collection date for primary outcome measure) |